BLCO Insider Luc Bonnefoy Sells Shares
Luc Bonnefoy, BLCO's President of Surgical, sold 1,008 shares on June 12.
Key Points
- Luc Bonnefoy, President of Surgical at BLCO, sold 1,008 shares for about $15,200.64 on June 12, 2026.
- BLCO shares are trading around $15.00 with active institutional interest from Deutsche Bank and D. E. Shaw.
- Analysts from firms like Evercore and Citigroup have maintained their ratings with price targets ranging from $16 to $21.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Luc Bonnefoy, President of Surgical at BLCO, sold 1,008 shares of the company on June 12, 2026. The shares were sold at an average price of $15.08 each, totaling approximately $15,200.64. This transaction was not part of a pre-planned trading program.
Other Institutional Activity in BLCO
BLCO has seen varied activity from institutional investors. Deutsche Bank AG added 78,441 shares, bringing its total to 3,528,441 shares valued at about $56.1 million. D. E. Shaw & Co., Inc. significantly increased its position by 304,542 shares to a total of 3,151,167 shares worth approximately $50.1 million. Meanwhile, Silver Point Capital L.P. reduced its holdings by 320,000 shares, now holding 2,245,000 shares valued at $35.7 million.
Bausch + Lomb Corporation Stock Down 12.5%
BLCO shares are currently trading at approximately $15.00. The stock has been active with a 52-week range between $14.00 and $18.00. The company's market dynamics are closely watched, with a mix of buying and selling from both insiders and institutional investors.
Insider Buying and Selling at Bausch + Lomb Corporation
In addition to Luc Bonnefoy's sale, several insiders made notable transactions in late May. On May 26, Karen Ling, Russel Robertson, Steven Collis, John Paulson, and Thomas Ross Sr. each purchased 15,842 shares at an average price of $15.78.
Analysts Set New Price Targets
Analysts have maintained their positions on BLCO with various price targets. On April 30, 2026, Evercore ISI Group maintained a 'hold' rating with a $16 target. Citigroup and HC Wainwright & Co. have more optimistic views, maintaining 'buy' ratings with targets of $21 and $20, respectively, back in February.
Bottom Line
Luc Bonnefoy's recent sale is part of ongoing insider activity at BLCO, reflecting individual strategies rather than an overall trend. BLCO's stock remains under close watch by institutional investors and analysts, with varied opinions on its future performance. As always with 13F filings and insider transactions, these moves provide a snapshot of past actions, not necessarily current positions.
Get Bausch + Lomb Corporation alerts
New 13F filings, insider trades, and analyst moves on $BLCO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.